Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery

Summary

This study is being done to determine if lidocaine, administered during surgery and for 24 hours after surgery can reduce inflammation, thereby reducing the risk of atrial fibrillation and 30 day mortality after surgery. Participants undergoing cardiac surgery will be randomized to receive either lidocaine or placebo.

Timeline

Start

2009-02

Primary completion

2014-12-15

Completion

2014-12-15

Outcome

Outcome not reported

Stopped (Enrollment): “Problem with enrollment”

Drugs

Indications